Results 1 to 10 of about 21,378 (292)

Hereditary Hemorrhagic Telangiectasia

Pediatric Neurology Briefs, 1998
Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu disease, was the subject of an NIH workshop, organized by the National Heart, Lung, and Blood Institute, on July 10-11, 1997.
J Gordon Millichap
doaj   +6 more sources

Epistaxis due to hereditary hemorrhagic telangiectasia: A case report and literature review [PDF]

Journal of International Medical Research
Characterized by abnormalities of the blood vessel wall, hereditary hemorrhagic telangiectasia is an autosomal dominant disorder. Recurrent or spontaneous epistaxis is the most prevalent symptom of hereditary hemorrhagic telangiectasia, whose severity ...
Xiangnan Du, Yuting Lu, Xiaoxiao Luo, Xiaolin Cao   +3 more
doaj   +3 more sources

A missed case of hereditary hemorrhagic telangiectasia: A case report

SAGE Open Medical Case Reports, 2022
Hereditary hemorrhagic telangiectasia is a rare autosomal dominant disorder characterized by abnormal blood vessel formation. When an abnormal vascular architecture affects the lungs and central nervous system, serious complications can occur.
Jia Zhang, Gaoyun Pan, Yingying Zou, Xiaoshu Chen, Jingye Pan, Yi Wang, Shichao Quan, He Zou   +7 more
doaj   +2 more sources

HEREDITARY HEMORRHAGIC TELANGIECTASIA

Vision Pan-America, 2015
We describe a patient with clinical history of intermittent haemolacria associated to hereditary hemorrhagic telangiectasia, first seen and diagnosed by the ophthalmologist.
Messody Zagury, Marcos B.V. Albers, Sergio Felberg, Adriana V Portes, M. Cristina Nishiwaki-Dantas, Paulo E.C. Dantas   +5 more
doaj   +6 more sources

Hereditary Hemorrhagic Telangiectasia

Eurasian Journal of Medicine, 2019
-
Mehmet Gündoğdu, Aydoğan Albayrak
doaj   +5 more sources

Beyond epistaxis: cascade screening and presymptomatic treatment of hereditary hemorrhagic telangiectasia [PDF]

BMC Pediatrics
Background Hereditary Hemorrhagic Telangiectasia is an autosomal dominant vascular disorder with clinical features of recurrent epistaxis, mucocutaneous telangiectasias, or visceral arteriovenous malformations, yet its early signs may be overlooked in ...
Chen Xiang Ang, Hui-Lin Chin, Shu Zhen Teresa Tan   +2 more
doaj   +2 more sources

Safely Treating a Pulmonary Embolism in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report [PDF]

Clinical Case Reports
Hereditary Hemorrhagic Telangiectasia (HHT) is a rare autosomal dominant bleeding disorder. The incidence of venous thromboembolisms among HHT patients is significantly greater than the general population.
Christina Carfagnini, Manasa Kandula
doaj   +2 more sources

P- 18 TREATMENT WITH BEVACIZUMAB IN HIGH OUTPUT CARDIAC FAILURE DUE TO SEVERE HEPATIC COMPROMISE IN HEREDITARY HEMORRHAGIC TELANGIECTASIA PATIENTS: OBSERVATIONAL COHORT STUDY

Annals of Hepatology, 2023
Introduction and Objectives: Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant vascular dysplasia affecting 1/5000 individuals. Epistaxis, mucocutaneous telangiectasias and vascular malformations affecting internal organs (brain, lungs,
Carolina Vazquez, Juan Bandi, Marcelo Serra   +2 more
doaj   +1 more source

A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy

Orphanet Journal of Rare Diseases, 2022
Background For extreme hereditary hemorrhagic telangiectasia (HHT) disease, treatments such as intravenous bevacizumab are often utilized. However, whether its efficacy is similar across diverse races and ethnicities is unclear.
Panagis Galiatsatos, Cheri Wilson, Jaime O’Brien, Anna J. Gong, Dylan Angiolillo, James Johnson, Carlie Myers, Sara Strout, Stephen Mathai, Gina Robinson, Nicholas R. Rowan, Clifford R. Weiss   +11 more
doaj   +1 more source

Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report

Journal of Medical Case Reports, 2022
Introduction Hereditary hemorrhagic telangiectasia is an autosomal dominant condition with an estimated prevalence of 1 in 5000. It is characterized by the presence of abnormalities of vascular structures, and may affect many organ systems, including the
L. J. Walsh, C. Collins, H. Ibrahim, D. M. Kerins, A. P. Brady, T. M. O Connor   +5 more
doaj   +1 more source